Skip to main content

SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies Main banner

Tweets by SSO 2022 International Conference on Surgical Cancer Care Featuring Advanced Cancer Therapies

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

98 Views

Immuno-Oncology

HUB

non-CME

Adoptive Cellular Therapy Using TIL for Solid Tumors

Thursday, March 10, 2022

4:00 PM – 4:30 PM CST

Location:HUB Immuno-Oncology Zone

Session Moderator(s)

Peter Prieto, MD, MPH, FACS, FSSO

Assistant Professor, Surgical Oncology
University of Rochester Medical Center
Rochester, New York, United States

Participants should be aware of the following financial/non-financial relationships:

Peter A. Prieto, MD, MPH, FACS, FSSO: Disclosure information not submitted.

Presentations:

4:00 PM – 4:01 PM CST

Introductions
4:01 PM – 4:11 PM CST

Efficacy and Feasibility of Adoptive Cellular Therapy for Metastatic Melanoma: Are We Ready for Commercialization?
HUB Presenter: Young K. Hong, MD,MPH,FACS,FSSO – Cooper University Hospital
4:11 PM – 4:21 PM CST

Feasibility of Adoptive Cell Therapy Using TIL in Patients with Advanced Soft Tissue Sarcoma
HUB Presenter: John E. Mullinax, MD – H. Lee Moffitt Cancer Center
4:21 PM – 4:30 PM CST

Discussion and Q&A